Passot, C., Mulleman, D., Bejan-Angoulvant, T., Aubourg, A., Willot, S., Lecomte, T., . . . Ternant, D. (2016). The underlying inflammatory chronic disease influences infliximab pharmacokinetics. MAbs.
Citação norma ChicagoPassot, Christophe, et al. "The Underlying Inflammatory Chronic Disease Influences Infliximab Pharmacokinetics." MAbs 2016.
Citação norma MLAPassot, Christophe, et al. "The Underlying Inflammatory Chronic Disease Influences Infliximab Pharmacokinetics." MAbs 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.